Trials / Active Not Recruiting
Active Not RecruitingNCT04057352
Citadel Embolization Device Study
The Citadel Embolization Device Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Stryker Neurovascular · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular's Next Generation Target Detachable Coil (hereafter referred to as the Citadel Embolization Device), when used with Target Detachable Coils, in the treatment of wide-neck intracranial aneurysms.
Detailed description
In this study, use of the Citadel Embolization Device will be limited to a population of patients with unruptured or ruptured wide-neck aneurysms who meet all study eligibility criteria. The Citadel Embolization Device is intended to endovascularly obstruct or occlude blood flow in intracranial aneurysms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Citadel Embolization Device | The Citadel Embolization Device is intended to endovascularly obstruct or occlude blood flow in intracranial aneurysms. |
Timeline
- Start date
- 2019-07-18
- Primary completion
- 2026-11-15
- Completion
- 2026-11-15
- First posted
- 2019-08-15
- Last updated
- 2026-03-30
Locations
25 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04057352. Inclusion in this directory is not an endorsement.